Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 1992

AMSA Combination ChernotheraDvId in Patients with Acute Myelogenous Leukemia Unsuitable for Standard Antileukemic Treatment

Forty-eight patients with acute myelogenous leukemia (AML) not eligible for anthracycline or mitoxantrone treatment, mostly due to cardiac contraindications,...

1 citationsDOI: https://doi.org/10.3109/10428199209051016
AMSA Combination ChernotheraDvId in Patients with Acute Myelogenous Leukemia Unsuitable for Standard Antileukemic Treatment